Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR.

Bivona TG, Hieronymus H, Parker J, Chang K, Taron M, Rosell R, Moonsamy P, Dahlman K, Miller VA, Costa C, Hannon G, Sawyers CL.

Nature. 2011 Mar 24;471(7339):523-6. doi: 10.1038/nature09870.

2.

Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review.

Murphy M, Stordal B.

Drug Resist Updat. 2011 Jun;14(3):177-90. doi: 10.1016/j.drup.2011.02.004. Epub 2011 Mar 24. Review.

PMID:
21435938
3.

Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer.

Gadgeel SM, Wozniak A.

Clin Lung Cancer. 2013 Jul;14(4):322-32. doi: 10.1016/j.cllc.2012.12.001. Epub 2013 Jan 16. Review.

PMID:
23332287
4.

EGFR and NF-κB: partners in cancer.

Shostak K, Chariot A.

Trends Mol Med. 2015 Jun;21(6):385-93. doi: 10.1016/j.molmed.2015.04.001. Epub 2015 May 13. Review.

PMID:
25979753
5.

Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors.

Juchum M, Günther M, Laufer SA.

Drug Resist Updat. 2015 May;20:12-28. doi: 10.1016/j.drup.2015.05.002. Epub 2015 May 12. Review.

PMID:
26021435
6.

Epithelial growth factor receptor-activated nuclear factor κB signaling and its role in epithelial growth factor receptor-associated tumors.

Pan D, Lin X.

Cancer J. 2013 Nov-Dec;19(6):461-7. doi: 10.1097/PPO.0000000000000001. Review.

PMID:
24270344
7.

[Relationship of epidermal growth factor receptor in lung development].

Li HJ, Liu Y, Hao HS, DU WH, Zhao XM, Wang D, Qin T, Ma YJ, Zhu HB.

Yi Chuan. 2012 Jan;34(1):27-32. Review. Chinese.

PMID:
22306870
8.

NF-kappaB fans the flames of lung carcinogenesis.

Wong KK, Jacks T, Dranoff G.

Cancer Prev Res (Phila). 2010 Apr;3(4):403-5. doi: 10.1158/1940-6207.CAPR-10-0042. Epub 2010 Mar 30. Review.

9.

Alteration in NFKBIA and EGFR in glioblastoma multiforme.

Komotar RJ, Starke RM, Connolly ES, Sisti MB.

Neurosurgery. 2011 Jun;68(6):N14-5. doi: 10.1227/01.neu.0000398206.71573.50. Review. No abstract available.

PMID:
21778941
10.

Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities.

Vallath S, Hynds RE, Succony L, Janes SM, Giangreco A.

Eur Respir J. 2014 Aug;44(2):513-22. doi: 10.1183/09031936.00146413. Epub 2014 Jan 16. Review.

Supplemental Content

Support Center